Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. - Wikidata - wikimedia - TriplyDB

Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.

Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.

http://www.wikidata.org/entity/Q39834604

about

A Survey of Therapeutic Effects of Artemisia capillaris in Liver Diseases Role of cytokines and chemokines in non-alcoholic fatty liver disease Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells Expression of fatty acid synthase in nonalcoholic fatty liver disease.Hepatic stellate cells and parasite-induced liver fibrosis.Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide.Infection with Porphyromonas gingivalis exacerbates endothelial injury in obese mice.Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices.Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes.Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) increases human hepatic stellate cell activation.Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice.Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice Mechanisms of hepatic fibrogenesis.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats.Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease.Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative.Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.Melatonin protects against lipid-induced mitochondrial dysfunction in hepatocytes and inhibits stellate cell activation during hepatic fibrosis in mice.Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21.The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations.

P2860

Q26781118-4AFFD994-7BF4-4C53-B4F8-30643D139D4D Q26830328-7503293A-144D-4ACC-BD73-8168E4C97C92 Q27331466-7601710E-192F-4BE3-8F32-E26A8389D151 Q28071596-85217367-8137-42D2-A0B0-C3EA20D0D0F9 Q33807881-9D11A988-2373-4E23-A617-8FD43818ACBB Q33962008-1F59D424-066B-4549-9B81-928D2352BC59 Q34043746-D4FB17CB-3B5B-4791-91E6-189D485D68AF Q34065528-5CEB826A-7469-498B-ACCA-6FC5F9F58763 Q34379651-E12D2253-0817-46EF-BA46-7951C249B306 Q34976113-F278DA1E-100D-4EC3-AB23-6993E192E248 Q35107757-2F782020-9BDA-4E17-9FC1-08F363E1C07D Q35429910-7E9401AA-90E7-40FC-B15D-BA47E69C7CEA Q35474502-BF1359CA-F5A8-450C-BB26-495105533329 Q35532289-3AFB2845-3924-4CCC-A930-23DE1DA1F627 Q35870151-769B4C5B-9064-457D-A078-FF453F380DC3 Q35976370-ED1B86F6-4E71-40CA-BFB8-7EFBDEE7C991 Q36129673-AB7B6258-2482-4F58-B9C7-AD55D8D9DF58 Q36544964-76D3A780-FC5D-4F1B-BA93-A5A1D879E08E Q36689584-89C07B25-BD9B-47A3-A984-F195AC26D226 Q37054565-88257942-384D-4B3B-98DE-200D12A021C7 Q37121662-7A9583B5-888D-4A5E-AC7D-9262D3F0D870 Q37193179-77242F53-939B-43BB-868F-0D72614C3C05 Q37706542-857E8B86-1609-424E-ADBF-A1AE8523BB9E Q37865859-0A782F58-CA6D-440D-91F4-C4A5BF71947F Q38018841-DFFEE156-DF66-43AA-BC28-FE624D5558B8 Q38310825-B2838957-2053-44A3-887B-0510C2AD2875 Q38336979-BE19F5A8-DDE2-48FB-A343-012B1BEA18C9 Q38845334-C7A2E7E0-151A-4AF8-8C35-7B67E56AA32A Q39062048-B32CFB3A-9AD3-4929-93AF-36D98F4A1923 Q39657367-BE029D4F-736B-4DB5-A9BA-D613FC543ADD Q39704003-00AA312B-35F3-47D1-A549-4C36E4C14057 Q40707212-4C6E9BA4-BDDC-4C82-BBF3-7C4422C83ED9 Q41614727-10036C81-9949-438F-8A3D-2E7658D62B5E Q43712492-06EC5C77-8094-4583-AD39-69075E21CD13 Q46411139-F01B5225-54FE-46AE-8946-0B9121B93040 Q47610112-47F34148-4587-4169-B0A3-90434D3A93B1 Q47664021-E1A81424-474F-4892-96A4-B2C0AA6DBF4F Q47675507-0DF23DF4-FBF0-436B-8678-EC2B1872FA72 Q49819768-8672B0C9-7F2E-49AC-90D8-FA89A28A4E8F Q49994994-B57A1824-595A-4266-B657-413FB6C2B544

P2860

Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.

http://www.wikidata.org/entity/Q39834604

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@en

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@nl

type

label

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@en

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@nl

prefLabel

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@en

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@nl

P1433

Q39834604-ED6849D2-5689-4D24-AF63-0DB166757890

P1476

Q39834604-50A2ADD6-E0B2-4D0D-8620-224A5B20DD23

P2093

Q39834604-08229610-7CFA-4BC5-8200-894A2C7C9983

Q39834604-33666FDC-1595-4E82-BA9F-6A863DECEEA7

Q39834604-A3DDF063-D9BB-4746-8FA4-165A6CA87530

Q39834604-ADE3CA0A-26C4-464D-85A1-477FB3D3F94A

Q39834604-E6F8BF0B-DEBE-4711-87CF-0717FD2B0CE1

Q39834604-EED24689-4F5C-4E26-8476-8115711F4227

P2860

Q39834604-08D289CB-7A2F-4B6A-B62C-9973CA1B84BE

Q39834604-17541558-F84C-4C2D-90FB-5A02441562A3

Q39834604-1CA57372-D0AF-4790-A998-A2C047782C85

Q39834604-240E5729-84CB-46F0-857F-DDD368D77D97

Q39834604-2EBC027D-36FC-4258-9A61-282FDB8303C3

Q39834604-37B9C15B-D8EB-47C6-8C27-35EFC7D4A75C

Q39834604-38B8E5D3-1A18-4AA4-AE5C-4E056A15E916

Q39834604-3F783C03-27F5-4F60-B02A-17FDAC702FD0

Q39834604-4B5E1470-014E-4D62-94C6-6D1D77B03802

Q39834604-550F0E82-DE6E-4B64-82E6-AC9C4D91A2C7

P2888

Q39834604-938DCE46-2753-4339-9D2E-1AEFD550E2D6

P304

Q39834604-23D9BC4D-55A4-4F9D-8730-A4D01337BAD8

P31

Q39834604-CB79B8DB-BF9F-4E73-A87D-58A0D4D2573F

P356

Q39834604-AE48EE44-581D-4F71-8C0E-4579A92EF94E

P433

Q39834604-A5B5CE85-E45A-492F-A4A6-2BB539F491E8

P478

Q39834604-0EA07CA4-C202-4BC3-890B-13A46B8E7FC4

P50

Q39834604-15A7075C-0385-440E-B67C-CA6906CCCDF4

Q39834604-3F2D43E6-D945-498A-B017-7F127DD38082

P577

Q39834604-99247914-AB10-4517-A432-D049C7A0D5D3

P5875

Q39834604-A5BD41BE-AD83-4DE0-B743-337F2B7931D7

P698

Q39834604-B2BD170F-CF4D-4CDF-B6FC-AE2EB765D599

P356

P1433

P1476

Lipid accumulation in hepatocy ...... ion of hepatic stellate cells.

@en

P2093

Christoph Dorn

http://www.w3.org/2001/XMLSchema#string

Claus Hellerbrand

http://www.w3.org/2001/XMLSchema#string

Cornelius Bollheimer

http://www.w3.org/2001/XMLSchema#string

Hella Wobser

http://www.w3.org/2001/XMLSchema#string

Roland Büttner

http://www.w3.org/2001/XMLSchema#string

Thomas Amann

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

Steatohepatitis: a tale of two "hits"?

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.

Mitochondrial abnormalities in non-alcoholic steatohepatitis.

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.

Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.

The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

P2888

P304

996-1005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CR.2009.73

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Jürgen Schölmerich

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26311395

http://www.w3.org/2001/XMLSchema#string

P698

19546889

http://www.w3.org/2001/XMLSchema#string